Investors & Media

Press Releases

Press Releases

Press Releases

  • May 23, 2022

    Anokion Announces Positive Data from Phase 1 ACeD Clinical Trial Evaluating KAN-101 as a Treatment for Celiac Disease Presented in a Plenary Session at DDW 2022

    Read More
  • January 06, 2022

    Anokion Announces Progress Across Pipeline of Novel Autoimmune Programs

    Read More